CALD1 and non-small cell lung carcinoma: Patients with increased expression of l-CaD in their tumors have a poor response to chemoradiotherapy [17,22,29,38], and in vitro silencing of l-CaD by siRNA induced resistance to 5FU treatment in colon cancer cell lines [17] and in non-small-cell lung cancer cells [43].